EGFR and neoplasm: Targeted liposomes induce 90% tumour growth inhibition at 8.1% of the equivalent dose of nanoliposomal formula. Photoactivation is ineffective without EGFR targeting. Targeted liposomes reduce collagen density by >90% and increase collagen nonalignment by >103-fold.